TLR7-iODN (inhibitory ODN) Endotoxin-free (sterile) Cat. No. #IAX-200-056

TLR7 selective antagonist.

[1] A TLR7 antagonist restricts interferon-dependent and -independent immunopathology in a mouse model of severe influenza. Rappe JCF, et al. J. Exp. Med. (2021); 218:e20201631

£289.52

Choose your options

Sequence

5’-tgcttgcaagcttgcaagca-3’ (lower case letters: phosphorothioate linkage: nuclease resistant)

Synonyms

TLR7 inhibitory ODNs (iODNs)

MW

6,761 g/mol

Formulation

Lyophilised. Sterile. 100µg size includes 1.5ml ddWater Endotoxin-free (sterile) (Cat. No.: IAX-900-002-LD15). 1mg size includes 10ml ddWater Endotoxin-free (sterile)
(Cat. No.: IAX-900-002-L010).

Endotoxin-free

Bacterial Endotoxin Test (kinetic turbidimetric LAL method) according to Ph. Eur. 9.

Passed according to specification:
Endotoxin-free: <0.002 EU/µg.

Sterility

Filter method: according to Ph. Eur. 9.

Passed according to specification:

• No growth in Thioglycolate medium at 30-35°C after 14 days.

• No growth in Soybean Casein Digest Broth (TSB) at 20-25°C after 14 days.

Handling

Keep sterile. Reconstitution: Dissolve total vial content in sterile endotoxin-free water or PBS. Add 50% of solvent and let dissolve for 10min. Add remaining 50% of the solvent and mix thoroughly. Moderate warming may aid dissolving.

Activity

iODN for in vivo use in rodents (50-150µg per injection).

For inactive control without agonistic nor antagonistic activity: CTRL2-ODN (Cat. No.: IAX-200-208).


Download Product Resources

Product Data Sheet
Safety Data Sheet

Brand Innaxon
Code IAX-200-056-M001

Download Product Resources

Product Data Sheet
Safety Data Sheet